Allogeneic transplantation of blood stem cells concentrated by density gradients
- PMID: 2857650
Allogeneic transplantation of blood stem cells concentrated by density gradients
Abstract
Discontinuous albumin density gradients were used to physically separate hemopoietic cells from immunocompetent lymphocytes in peripheral blood mononuclear cells of dogs. Transplantation of these stem cell concentrates into lethally irradiated allogeneic recipients restored hemopoiesis in nine of 12 animals. Tolerance and long-term survival, however, were achieved only in pairs matched for major histocompatibility antigens. These animals showed stable chimerism in bone marrow cells but transiently regenerated autochthonous cells demonstrable only in the peripheral blood. As compared with earlier studies using grafts of unseparated peripheral blood mononuclear cells, the numbers of CFUc transplanted were similar; the number of mononuclear cells, however, was reduced by a factor of 60. It thus appears that the granulocyte-macrophage colony-forming assay (GM-CFUc) is able to predict within limits the hemopoietic potential of a graft. Although very low numbers of blood-derived CFUc were effective (33,000-42,000/kg body weight), the superiority of blood stem cells over bone marrow grafts remains to be established.
Similar articles
-
Gradient separation of granulocytic progenitor cells (CFUc) from human blood mononuclear leukocytes.Exp Hematol. 1985 Feb;13(2):79-86. Exp Hematol. 1985. PMID: 2857652
-
Albumin density gradient purification of canine hemopoietic blood stem cells (HBSC): long-term allogeneic engraftment without GVH-reaction.Exp Hematol. 1979 Jul;7(6):277-88. Exp Hematol. 1979. PMID: 39771
-
Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients.Exp Hematol. 1996 Jul;24(8):902-13. Exp Hematol. 1996. PMID: 8690049
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.Blood Cells Mol Dis. 2008 Jan-Feb;40(1):48-54. doi: 10.1016/j.bcmd.2007.06.019. Epub 2007 Sep 10. Blood Cells Mol Dis. 2008. PMID: 17827036 Review.
Cited by
-
Five decades of progress in haematopoietic cell transplantation based on the preclinical canine model.Vet Comp Oncol. 2007 Mar;5(1):14-30. doi: 10.1111/j.1476-5829.2006.00114.x. Vet Comp Oncol. 2007. PMID: 19754798 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials